Date published: 2026-4-12

1-800-457-3801

SCBT Portrait Logo
Seach Input

KV1.3 Inhibitors

KV1.3 Inhibitors constitute a diverse group of compounds that target the KV1.3 potassium channel, a crucial component in cellular physiology. The inhibitors in this class vary in their structure and mode of action but share the common function of modulating the activity of the KV1.3 channel. The significance of these inhibitors lies in their ability to regulate the flow of potassium ions across cell membranes, which is fundamental in various physiological processes. Tetraethylammonium and 4-Aminopyridine are classic examples, blocking the potassium channel by binding to specific sites on the channel. Peptide toxins like Margatoxin, ShK toxin, Agitoxin-2, and MgTX are particularly effective, specifically targeting KV1.3 and blocking its activity. These peptides bind to the external portions of the channel, preventing the flow of potassium ions. Correolide and Psora-4 are other examples of compounds that selectively inhibit KV1.3 channels, underlining the diversity of molecules capable of interacting with these channels. Moreover, compounds like Anandamide, PAP-1, and Clofazimine demonstrate the variety of chemical structures that can interact with KV1.3.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

CP 339818 hydrochloride

185855-91-8sc-203903
sc-203903A
10 mg
50 mg
$155.00
$660.00
(0)

CP 339818 hydrochloride acts as a selective KV1.3 inhibitor, exhibiting a unique binding affinity for the channel's voltage-sensing domains. Its structural conformation allows for precise interactions with critical amino acid residues, stabilizing the inactivated state of the channel. This modulation alters ion flow dynamics, impacting cellular excitability. Additionally, its lipophilic characteristics may enhance membrane permeability, influencing its distribution and interaction with lipid bilayers.

Tetraethylammonium acetate tetrahydrate

67533-12-4sc-253665
25 g
$65.00
(0)

Blocks the potassium channel by binding to the external mouth of the channel.

Charybdotoxin

95751-30-7sc-200979
100 µg
$401.00
9
(0)

Charybdotoxin is a potent inhibitor of KV1.3 channels, characterized by its ability to bind selectively to the channel's pore region. This interaction disrupts potassium ion conductance, leading to altered electrochemical gradients across membranes. The toxin's unique structure facilitates specific hydrogen bonding and hydrophobic interactions with key residues, enhancing its inhibitory efficacy. Its stability in physiological conditions allows for prolonged effects on cellular ion homeostasis, influencing various signaling pathways.

Agitoxin

78207-24-6sc-3582
5 µg
$94.00
(0)

Agitoxin is a selective KV1.3 channel inhibitor that exhibits a unique binding affinity for the channel's extracellular domain. This interaction stabilizes the closed conformation of the channel, effectively blocking potassium ion flow. The toxin's distinct amino acid composition promotes specific electrostatic interactions with channel residues, enhancing its inhibitory potency. Additionally, Agitoxin's structural rigidity contributes to its resistance against proteolytic degradation, ensuring sustained channel modulation.

4-Aminopyridine

504-24-5sc-202421
sc-202421B
sc-202421A
25 g
1 kg
100 g
$38.00
$1155.00
$122.00
3
(2)

Known to block voltage-gated potassium channels including KV1.3.

CDDO Methyl Ester

218600-53-4sc-504720
10 mg
$220.00
(0)

Specifically inhibits KV1.3 channels.

Psora-4

724709-68-6sc-253325
5 mg
$196.00
(0)

Blocks KV1.3 channels selectively.

5-(4-Phenoxybutoxy)psoralen

870653-45-5sc-252247
sc-252247A
5 mg
25 mg
$118.00
$728.00
1
(0)

Potent and selective inhibitor of KV1.3 channels.

Clofazimine

2030-63-9sc-234402
5 g
$198.00
6
(2)

Known to inhibit KV1.3 channels.